PERCHERON THERAPEUTICS LIMITED — Director's Dealing 2012

Jul 2, 2012

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001. Amended 01/01/11

	Antisense Therapeutics Limited(ASX:ANP)
Name of Entity:
	41 095 060 745
ABN:

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director:	Mr Robert W Moses
Date of Last Notice:	7 May 2012

Part 1 – Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

director” should be disclosed in this part.
Direct or Indirect Interest	a) Directb) Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest.		b) Spouse
Date of change		3rdJuly 2012
No. of securities held prior to change		SharesOptionsDirect-240,000Indirect14,833,3331,744,370Total14,833,3331,984,370
Class	a) Ordinary Sharesb) Ordinary Shares
Number acquired			SharesOptionsa) 240,000-b) 1,744,370-1,984,370-
			Shares	Options
		Direct	a) 240,000	-
		Indirect	b) 1,744,370	-
		Total	1,984,370	-

• See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Number disposed			SharesOptionsa)240,000b)1,744,3701,984,370	SharesOptionsa)240,000b)1,744,3701,984,370
			Shares	Options
		Direct		a)240,000
		Indirect		b)1,744,370
		Total		1,984,370
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	a) Nil cents per share as per 2008 EmployeeOption Planb) 1.1 cents per share
No. of securities held after change			SharesOptions240,000-16,577,703-16,817,703-
			Shares	Options
		Direct	240,000	-
		Indirect	16,577,703	-
		Total	16,817,703	-
Nature of changeExample: on-market trade, off-market trade, exercise of options,issueofsecuritiesunderdividendreinvestmentplan,participation in buy-back		Exercise of Options

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

director” should be disclosed in this part.
Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to which theinterest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation	N/A
Interest after change	N/A

Part 3 – Closed period

Part 3 – Closed period
Were the interests in the securities or contractsdetailed above traded during a +closed periodwhere prior written clearance was required?	No
If so, was prior written clearance provided toallow the trade to proceed during this period?	N/A
If prior written clearance was provided, on whatdate was this provided?	N/A

==> picture [36 x 22] intentionally omitted <==

The CFO Solution

03/07/2012

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011